Skip to main content
. 2015 Sep 3;2015:651879. doi: 10.1155/2015/651879

Figure 2.

Figure 2

Overall (0–120 h) complete response (no emesis, no rescue medication) rates over multiple chemotherapy cycles: NEPA versus oral palonosetron (Study 2) and NEPA versus aprepitant regimen (Study 3).